Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
Journal of Child and Adolescent Psychopharmacology|September 14, 2021
A Randomized, Double-Blind, Controlled Trial of Lithium Versus Quetiapine for the Treatment of Acute Mania in Youth with Early Course Bipolar DisorderLuis R Patino, Christina C Klein, Jeffrey R Strawn, et al.Human Psychopharmacology|December 7, 2007
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trialAnna I Guerdjikova, Susan L McElroy, Renu Kotwal, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 2006
Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's diseaseJudith A Strong, Arif Dalvi, Fredy J Revilla, et al.Pharmacology, Biochemistry, and Behavior|April 6, 2007
The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotionLaurel M Pritchard, Amy Hauck Newman, Robert K McNamara, et al.Journal of Child and Adolescent Psychopharmacology|May 21, 2024
Adherence Rates and Barriers to Second-Generation Antipsychotic Medication Use in Youth with Bipolar Spectrum Disorders Who Have Overweight/ObesityChristina C Klein, Avani C Modi, Jeffrey A Welge, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administrationNeil M Richtand, Jeffrey A Welge, Beth Levant, et al.Early Intervention in Psychiatry|October 22, 2015
Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarkerRobert K McNamara, Ronald Jandacek, Patrick Tso, et al.Psychiatry Research|October 20, 2015
First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapineRobert K McNamara, Ronald Jandacek, Patrick Tso, et al.Journal of Affective Disorders|March 17, 2023
Brain functional activation and first mood episode in youth at risk for bipolar disorderFabiano G Nery, Jeffrey A Welge, David Fleck, et al.JAACAP Open|November 18, 2024
Metformin for Overweight and Obese Children With Bipolar Spectrum Disorders Treated With Second-Generation Antipsychotics (MOBILITY): Protocol and Methodological Considerations for a Large Pragmatic Randomized Clinical TrialJeffrey A Welge, Christoph U Correll, Michael T Sorter, et al.Pageof 12